High dose versus low dose intravesical interferon-alpha 2b for the treatment of carcinoma in situ of the bladder

This review has been withdrawn.

The reason for withdrawal and previous versions are archived and accessible within the withdrawn record in the Cochrane Library.

Health topics:

Cancer > Bladder

Urology > Cancer > Bladder cancer

Published:

29 June 2013

Authors:

Dong Z, Wang Z, Liu T

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Dong Z, Wang Z, Liu T. High dose versus low dose intravesical interferon-alpha 2b for the treatment of carcinoma in situ of the bladder. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD007520. DOI: 10.1002/14651858.CD007520.pub2